← Back to Browse

iRhythm Technologies, Inc.

IRTC • Healthcare

Compare
76
Grade B
Compass

About iRhythm Technologies, Inc.

iRhythm Technologies, Inc. is a digital healthcare enterprise dedicated to offering portable electrocardiogram (ECG) monitoring solutions to individuals in the United States who face the risk of cardiac arrhythmias. Its primary offering, the Zio service, provides a comprehensive ambulatory cardiac monitoring system. This system ingeniously combines a wireless, patch-based, and wearable biosensor—specifically embodied in products like the Zio XT and AT monitors—with a sophisticated cloud-based data analysis platform.

Current Price
$116.13
Market Cap
$5.7B

Quality Assessment

iRhythm Technologies, Inc. is a above-average quality healthcare company with a Compass Score of 76. Solid fundamentals, with a few weaker spots. Worth a look for a diversified portfolio.

Score Breakdown

The Compass Score is based on 6 quality factors identified by academic research.

Click any factor to see detailed metrics

Valuation Metrics

Click any metric for details

Fair Value

Pro

See whether this stock trades above or below its fair value.

Wall Street View

Consensus
Hold
Analysts
9
Price Target
🔒
Upside
🔒

Catalyst Signal

Plus

Recent earnings beats and analyst-upgrade momentum. How it works

Catalyst Score
🔒
EPS Beat Streak
🔒
Net Upgrades (180d)
🔒

See recent earnings beats and analyst-upgrade momentum.

Analyst Track Record

Plus

See each covering analyst's historical hit rate.

Financial Health

Plus

Click any metric for details

See bankruptcy-risk and financial-strength scores for this company.

Growth Projections

Plus
Projected EPS Growth
🔒
Projected Revenue Growth
🔒

See projected EPS and revenue growth for this company.

Technical Overview

Click any metric for details

Important Disclaimer

The Compass Score is for educational purposes only and does not constitute financial advice. Past performance does not guarantee future results. Always do your own research and consider consulting a financial advisor before making investment decisions.